- ►annals.org [PDF] D Grady, NK Wenger, D Herrington, S Khan, C … - Annals of Internal Medicine, 2000 - Am Coll Physicians Deborah Grady, MD, MPH; Nanette K. Wenger, MD; David Herrington, MD, MHS; Steven
Khan, MD; Curt Furberg, MD; Donald Hunninghake, MD; Eric Vittinghoff, PhD; and
Stephen Hulley, MD, MPH, for the Heart and Estrogen/progestin Replacement ... Cited by 527 - Related articles - BL Direct - All 8 versions
- ►prsjournal.com MA Shiffman - Plastic and Reconstructive Surgery, 2002 - journals.lww.com What effort does it take to require that a patient cease estrogenic hormones at
least 3 weeks before surgery and 2 weeks after surgery? If the patient refuses
to stop taking the hormones or cannot stop taking them because of the ... Cited by 3 - Related articles - BL Direct - All 7 versions
MA Shiffman - Journal of Women's Health, 2003 - liebertonline.com O RAL CONTRACEPTIVES ( ESTROGENS ) have been associated with a significant risk
of throm- boembolic disease. In fact, the Physicians' Desk Reference warns
physicians and patients about this risk when taking estrogenic hormones. ... Cited by 5 - Related articles - BL Direct - All 6 versions
A HORMONALES - semcc.com Introducción Los anticonceptivos orales (estrógenos) se asocian con riesgo
significativo de tromboembolia. El Physicians´s Desk Reference advierte a los
médicos ya los pacientes sobre este riesgo.1 “Riesgo de producir ... Related articles - View as HTML - All 2 versions
D Grady, G Sawaya - The American journal of medicine, 1998 - Elsevier Use of oral contraceptive pills increases risk of venous thromboembolism [1 and
2], and this increased risk is thought to be due to the estrogen contained in
the pills. The biologic potency of the estrogens generally used in ... Cited by 25 - Related articles - BL Direct - All 7 versions
H Jick, LE Derby, MW Myers, C Vasilakis, KM … - Obstetrical & Gynecological Survey, 1997 - journals.lww.com Skip Navigation Links Home > May 1997 - Volume 52 - Issue 5 > Risk of Hospital
Admission for Idiopathic Venous Thromboembo... ... Jick, Hershel; Derby, Laura
E.; Myers, Marian Wald; Vasilakis, Catherine; Newton, Katherine M. Cited by 562 - Related articles - BL Direct - All 8 versions
E Daly, MP Vessey, MM Hawkins, JL Carson, … - Obstetrical & Gynecological Survey, 1997 - journals.lww.com Cases were women, aged 45 to 64 years, recruited from local hospitals, who were
suspected of having VTE, as defined as DVT, PE, or both. Women were excluded if
they were found to have any condition that predisposes to DVT, including ... Cited by 726 - Related articles - BL Direct - All 7 versions
- ►highwire.org SP Gutthann, LAG Rodriguez, J Castellsague, … - Bmj, 1997 - bmjcom.highwire.org Study population A cohort of 416 914 women, 50 to 79 years old, registered in
the General Practice Research Database between 1 January 1991 and 31 October
1994 was identified. Those women with a history of venous thromboembolic ... Cited by 313 - Related articles - BL Direct - All 13 versions
F Grodstein, MJ Stampfer, SZ Goldhaber, JAE … - Obstetrical & Gynecological Survey, 1997 - journals.lww.com The relationship between oral contraceptive (OC) use and venous thrombosis and
pulmonary embolism (PE) has been well established and has caused many physicians
to extrapolate the risk to the use of postmenopausal hormone replacement ... Cited by 530 - Related articles - BL Direct - All 10 versions
E Høibraaten, M Abdelnoor, PM Sandset - Thrombosis and haemostasis, 1999 - ncbi.nlm.nih.gov Recent epidemiological studies on hormone replacement therapy (HRT) containing
mainly conjugated equine estrogens indicate increased risk for venous
thromboembolism (VTE). The purpose of the present epidemiological study was ... Cited by 117 - Related articles - BL Direct - All 3 versions
